OpenURL Connection Search

Select item for more details and to access through your institution.

Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors.
Published in:
Neuroendocrinology, 2018, v. 107, n. 1, p. 1, doi. 10.1159/000481506
By:
- Briest, Franziska;
- Grass, Irina;
- Sedding, Dagmar;
- Möbs, Markus;
- Christen, Friederike;
- Benecke, Joana;
- Fuchs, Karolin;
- Mende, Stefanie;
- Kaemmerer, Daniel;
- Sänger, Jörg;
- Kunze, almut;
- Geisler, Christina;
- Freitag, Helma;
- Lewens, Florentine;
- Worpenberg, Lina;
- Iwaszkiewicz, Sara;
- Siegmund, Britta;
- Walther, Wolfgang;
- Hummel, Michael;
- Grabowski, Patricia
Publication type:
Article
Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease.
Published in:
Neuroendocrinology, 2017, v. 105, n. 1, p. 90, doi. 10.1159/000448843
By:
- Freitag, Helma;
- Christen, Friederike;
- Lewens, Florentine;
- Grass, Irina;
- Briest, Franziska;
- Iwaszkiewicz, Sara;
- Siegmund, Britta;
- Grabowski, Patricia
Publication type:
Article
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.
Published in:
Cancers, 2020, v. 12, n. 11, p. 3448, doi. 10.3390/cancers12113448
By:
- Busse, Antonia;
- Mochmann, Liliana H.;
- Spenke, Christiane;
- Arsenic, Ruza;
- Briest, Franziska;
- Jöhrens, Korinna;
- Lammert, Hedwig;
- Sipos, Bence;
- Kühl, Anja A.;
- Wirtz, Ralph;
- Pavel, Marianne;
- Hummel, Michael;
- Kaemmerer, Daniel;
- Baum, Richard P.;
- Grabowski, Patricia
Publication type:
Article
Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells.
Published in:
Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1308686
By:
- von Hessert-Vaudoncourt, Claus;
- Lelek, Sara;
- Geisler, Christina;
- Hartung, Teresa;
- Bröker, Vanessa;
- Briest, Franziska;
- Mochmann, Liliana;
- Jost-Brinkmann, Fabian;
- Sedding, Dagmar;
- Benecke, Joana;
- Freitag, Helma;
- Wolfshöfer, Sebastian;
- Lammert, Hedwig;
- Nölting, Svenja;
- Hummel, Michael;
- Schrader, Jörg;
- Grabowski, Patricia
Publication type:
Article
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
Published in:
PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182852
By:
- Nölting, Svenja;
- Rentsch, Jakob;
- Freitag, Helma;
- Detjen, Katharina;
- Briest, Franziska;
- Möbs, Markus;
- Weissmann, Victoria;
- Siegmund, Britta;
- Auernhammer, Christoph J.;
- Aristizabal Prada, Elke Tatjana;
- Lauseker, Michael;
- Grossman, Ashley;
- Exner, Samantha;
- Fischer, Christian;
- Grötzinger, Carsten;
- Schrader, Jörg;
- Grabowski, Patricia;
- null, null
Publication type:
Article

Found: 5

Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors.

Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease.

Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.

Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells.

The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.